Randall W. Velliquette
New York Blood Center
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Randall W. Velliquette.
Transfusion | 2006
Sally A. Campbell-Lee; Jinhuan Liu; Randall W. Velliquette; Gregory R. Halverson; R. Sue Shirey; Asok Chaudhuri; Marion E. Reid; Paul M. Ness; William M. Baldwin
BACKGROUND: A murine model would be useful to identify which immune mechanisms could be manipulated to treat or prevent red blood cell (RBC) alloimmunization in patients who become sensitized to multiple or widely expressed antigens.
Transfusion | 2005
Kim Hue-Roye; Asok Chaudhuri; Randall W. Velliquette; Susan Fetics; Rebecca Thomas; Mary Balk; Franz F. Wagner; William A. Flegel; Marion E. Reid
BACKGROUND: More than 20 years ago, a proband was described whose red blood cells (RBCs) typed Sc:1,−2,3. His serum sample contained an immunoglobulin G alloantibody that reacted with all RBCs tested except his own, his brother’s, and those with the Sc:−1,−2 phenotype. Cloning of the SC gene allowed determination of the molecular basis associated with this novel high‐prevalence antigen.
Transfusion | 2013
Connie M. Westhoff; Sunitha Vege; Christine Halter Hipsky; Kim Hue-Roye; Tamara Copeland; Randall W. Velliquette; Trina Horn; Christine Lomas-Francis; Marion E. Reid
BACKGROUND: In the Rh blood group system, variant RhD and RhCE express several partial antigens. We investigated RH in samples with partial DIVa that demonstrated weak and variable reactivity with anti‐C.
Transfusion | 2013
Marion E. Reid; Kim Hue-Roye; Angela Huang; Randall W. Velliquette; Yoshihiko Tani; Connie M. Westhoff; Christine Lomas-Francis; Teresa Zelinski
Anti‐Lan has been implicated in hemolytic transfusion reactions and hemolytic disease of the fetus and newborn. The LAN blood group system is encoded by ABCB6, whose gene product, ABCB6, belongs to the ATP‐binding cassette (ABC) efflux transporter superfamily. The purpose of this study was to characterize additional alleles by analyzing DNA from 14 (13 unrelated) subjects whose red blood cells were serologically defined as Lan−, Lan+w/−, or Lan+w.
Transfusion | 2010
Flávia Pinheiro S. Costa; Kim Hue-Roye; Laima Sausais; Randall W. Velliquette; Eliete Da Costa Ferreira; Christine Lomas-Francis; Marion E. Reid
BACKGROUND: The Dombrock (Do) blood group system consists of six distinct antigens: Doa, Dob, Gya, Hy, Joa, and DOYA. Our finding of a pregnant patient whose red blood cells (RBCs) were Hy+ but whose serum contained an apparent alloanti‐Hy suggested the presence of a seventh antigen and prompted this study.
Transfusion | 2010
Beate Mayer; Nicole Thornton; Salih Yürek; Dwane E. Wylie; Kim Hue-Roye; Joyce Poole; Thilo Bartolmäs; Abdulgabar Salama; Christine Lomas-Francis; Randall W. Velliquette; Karina Yazdanbakhsh; Marion E. Reid
BACKGROUND: The Dombrock (Do) blood group system consists of five distinct antigens: Doa, Dob, Gya, Hy, and Joa. Our finding of a patient whose plasma contained a Do‐related alloantibody suggested the presence of a sixth antigen.
Transfusion | 2007
Kim Hue-Roye; Christine Lomas-Francis; Larisa Belaygorod; Douglas M. Lublin; Janet Barnes; Amy Chung; Karen Fung-Kee-Fung; Jeff Kinney; Ronit Goldman-Lavi; Vered Yahalom; Joyce Poole; Zdravko Ivankovic; Denden Alcantara; Marija Bekavac; Branka Golubic Cepulic; Randall W. Velliquette; Richard Mason; Marion E. Reid
BACKGROUND: The Cromer blood group system consists of nine high‐prevalence and three low‐prevalence antigens carried on decay‐accelerating factor (DAF). This report describes three new Cromer high‐prevalence antigens, named ZENA, CROV, and CRAM.
Transfusion | 2015
Connie M. Westhoff; Sunitha Vege; Christine Halter Hipsky; Trina Horn; Kim Hue-Roye; Jessica Keller; Randall W. Velliquette; Christine Lomas-Francis; Stella T. Chou; Marion E. Reid
RHCE*ceAG has the nucleotide change c.254C>G, which encodes p.Ala85Gly associated with altered expression of e antigen. We analyzed serologic and DNA‐based testing data on samples with RHCE*ceAG to determine its effect on antigen expression, linkage with RHD, and its prevalence in African Americans.
Transfusion | 2009
Gregory R. Halverson; Edith Tossas; Randall W. Velliquette; Cheryl A. Lobo; Marion E. Reid; Tom Frame; Lilian Castilho; Agnes H. Lee; Jill R. Storry; Magdalena Grodecka; Kazimiera Waśniowska; Maria Duk; Elwira Lisowska
BACKGROUND: The blood group antigens S and s are defined by amino acids Met or Thr at position 29, respectively, on glycophorin B (GPB). Commercial anti‐s reagents are expensive to produce because of the scarcity of human anti‐s serum. Our aim was to develop hybridoma cell lines that secrete reagent‐grade anti‐s monoclonal antibodies (MoAbs) to supplement the supply of human anti‐s reagents.
Transfusion | 2008
Randall W. Velliquette; Poonsub Palacajornsuk; Kim Hue-Roye; Sally Lindgren; Sarah J. Ilstrup; Carole Green; Christine Lomas-Francis; Marion E. Reid
BACKGROUND: The glycophorin (GP) molecule associated with the GP.Dane phenotype is a GP(A‐B‐A) hybrid that contains some amino acids encoded by the Pseudoexon 3 of GYPB and Asn45 of GPA and carries the low‐prevalence MNS antigens DANE and Mur. Serum from a woman of English ancestry contained an immunoglobulin M alloantibody to a high‐prevalence MNS antigen, and the purpose of this study was to identify the molecular basis of her phenotype.